Xconomy | National - Business + Technology in the Exponential Economy

Archives

by in
Entry Blogger Date Location
Biogen Idec Accused Again of Excessive CEO Pay, Lousy Performance, By Big Shareholder Luke Timmerman 11/20/09 Boston
Dendreon FDA Deadline Set For May 1 Luke Timmerman 11/20/09 Seattle
Metcalfe Reflects on $2.7B 3Com Buyout, MyPunchbowl Parent Adds New Punch, $30M More for Fate Therapeutics, & More Boston Deals News Ryan McBride 11/20/09 Boston
Under the Radar Deals: 12 Northwest Financings You Haven’t Heard About Gregory T. Huang 11/20/09 Seattle
Omeros Banks on First FDA Filing Next Year, Plans to “Unlock” Inaccessible Drug Targets Luke Timmerman 11/19/09 Seattle
ImmunoGen Nabs $1M From Amgen Luke Timmerman 11/19/09 Boston
Big Energy Collaborations Seen to Jump-Start Emerging Biofuels Technologies Bruce V. Bigelow 11/19/09 San Diego
Ligand Nabs $2M From Merck Luke Timmerman 11/19/09 San Diego
Tysabri, the MS Drug Haunted by Deadly Side Effect, Doesn’t Look So Deadly Anymore Luke Timmerman 11/19/09 Boston
Isis Extends Timeline on Cholesterol-Lowering Drug, FDA Delays Review of Cadence Pain Reliever, Fate Therapeutics Raises $30 Million, & More San Diego Life Sciences News Denise Gellene 11/19/09 San Diego
The Icos Alumni Guide, Trubion CEO Resigns, OVP Leads $30M Fate Deal, & More Seattle-Area Life Sciences News Luke Timmerman 11/19/09 Seattle
Beyond Anecdotes: Measuring Global Health Impact in Washington State Lisa Cohen 11/18/09 Seattle
Genzyme Halts Development of New Kidney Drug; A “Very Significant” Bust, Analyst Says Luke Timmerman 11/18/09 Boston
Biotech Meets Cleantech: GenVault Aims to Deep Six the Laboratory Deep Freeze Denise Gellene 11/18/09 San Diego
NanoString Forges Closer Ties With Broad Institute to See What Genetic Tool Can Really Do Luke Timmerman 11/18/09 Seattle
The Icos Alumni: Where Are They Now? Luke Timmerman 11/18/09 Seattle
Isis, Genzyme Cholesterol Drug Passes Test, But Investors Get Nervous About Liver Safety Luke Timmerman 11/17/09 San Diego
Bing Partners with Wolfram Alpha, OVP Leads $30M Fate Deal, Redfin Rakes In $10M, & More Seattle-Area Deals News Gregory T. Huang 11/17/09 Seattle
Trubion CEO Peter Thompson Steps Down, Arch’s Gillis To Step Up Temporarily Luke Timmerman 11/16/09 Seattle
Fate Therapeutics Bags $30M Venture Deal, Led by OVP, to Develop “Industrialized” Stem Cells Luke Timmerman 11/16/09 National
Cadence Hit By FDA Delay Luke Timmerman 11/13/09 San Diego
Genzyme Shares Tank After FDA Discovers Bits of Steel, Rubber in Five Different Drugs Luke Timmerman 11/13/09 Boston
Xconomy Videos: Sirtris’ Westphal and Millennium’s Dunsire Talk Cures for Ills of Big Pharma Ryan McBride 11/13/09 Boston
Cyntellect Raises $15.5M as it Expands Biotech Instrument Business Bruce V. Bigelow 11/12/09 San Diego
Cequent Seeks First Oral RNAi Trial Luke Timmerman 11/12/09 Boston
Oncothyreon Advances Cancer Drug Luke Timmerman 11/12/09 Seattle
Massachusetts Startup Funding Slowed Way Down in October—But Early Stage Deals Gained Robert Buderi 11/12/09 Boston
Trius Therapeutics Reveals Plans for IPO, SpectraScience Raises $4.3M, Sequenom Tightens its Belt, & More San Diego Life Sciences News Denise Gellene 11/12/09 San Diego
Alder’s Breakout $1B Deal, Kineta Teams With UW on Vaccines, Verathon Gets Acquired, & More Seattle-Area Life Sciences News Luke Timmerman 11/12/09 Seattle
Isis Spinoff Altair Therapeutics Closes $17M Venture Round For Asthma Drug Luke Timmerman 11/12/09 San Diego
Page 1 of 70 next page »
    

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, and beyond.

© 2007-2009, Xconomy, Inc. XCONOMY is a registered service mark of Xconomy, Inc. All rights reserved.
Site designed by Matthew Bouchard, produced by Andrew Koyfman, and powered by WordPress.